£89.36

Springer Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery

Price data last checked 93 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£89 today · usual range £0–£0 · best ever £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical
Generating forecast...
£89.99 £74.30 £77.73 £81.15 £84.57 £87.99 £91.42 09 June 2024 15 November 2024 23 April 2025 29 September 2025 08 March 2026

Price Distribution

Price distribution over 638 days • 5 price levels

Days at Price
Current Price
186 days 133 days 59 days 32 days · current 228 days 0 57 114 171 228 £76 £87 £88 £89 £90 Days at Price

Price Analysis

Most common price: £90 (228 days, 35.7%)

Price range: £76 - £90

Price levels: 5 different prices over 638 days

Description

The concept of immunologic responses against tumors is currently under intense scrutiny throughout the world. The evidence for the existence of tumor-specific transplantation antigens (TSTA) and specific immune reactions to them in experimental animals is overwhelming. The available data concerning human tumors are controversial. The reason for this is partially that antigens detectable on human tumors by in vitro assays have not been biologically characterized. In other words, we do not know if the antigens on human tumors are acting as the targets for immunologically mediated rejection processes in vivo. It was the purpose of this workshop to bring experimental tumor immunologists and clinical oncologists together in order to disclose facts and limits in tumor immunology. Clinicians were to learn how shaky the ground becomes once the experimentalist looks beyond the edge of the mouse cage. Tumor biologists heard the clinicians' urgent cry for controlled randomized trials of immunotherapy which thus reflects clearly that immunotherapy in its present form without knowledge of dose-effect-relationship does not work. Nobody would deny that the problem of human cancer smells of immunology, but since we are just about to taste it the essential ingredient might be different. In other words one might look at present rather at immunological epiphenomena than at mechanisms of tumor immul1lty operating in vivo. This problem was among others a central issue of this workshop.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 March 1979
Listed Since
21 February 2011

Barcode

No barcode data available

Similar Products You Might Like

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
98% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 08 Mar 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
98% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£135.04 24 Jan 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
98% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
97% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 12 Apr 2026
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
97% match

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Springer

£156.60 12 Jan 2026
Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)
97% match

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Springer

£144.12 10 Mar 2026
Cancer Immunotherapy (Advances in Immunology): Volume 90
97% match

Cancer Immunotherapy (Advances in Immunology): Volume 90

Academic Press

£61.72 17 Mar 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
97% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£188.36 08 Mar 2026
Critical Developments in Cancer Immunotherapy
97% match

Critical Developments in Cancer Immunotherapy

£421.00 12 Apr 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
97% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£73.91 07 Mar 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
97% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 24 Feb 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£67.77 10 Mar 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£147.58 12 Jan 2026
Cancer Immunology: A Translational Medicine Context
97% match

Cancer Immunology: A Translational Medicine Context

Springer

£116.13 27 Feb 2026
Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)
97% match

Progress in Cancer Immunotherapy: 909 (Advances in Experimental Medicine and Biology, 909)

Springer

£103.81 07 Jan 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
97% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£68.79 06 Mar 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
97% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£156.60 11 Jan 2026
Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)
97% match

Developments in T Cell Based Cancer Immunotherapies (Cancer Drug Discovery and Development)

Humana

£112.39 31 Jan 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
97% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

£110.06 13 Jan 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
97% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£146.40 24 Feb 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
97% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£176.00 09 Apr 2026
Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)
97% match

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Humana

£109.99 27 Feb 2026